Microviable to present at Symposium Microbiome and Cancer

Microviable has been invited to give a lecture at the Symposium “Microbiome and Cancer: a translational axis in todays oncology“, organized by Fundación Fisabio y and the Microbiome Hub.

Noelia Martinez Alvarez y David Rios-Covian, PhD will attend this event focused on the influence of the microbiome in oncology and the new therapeutic approaches on this field.

At this symposium, David Rios-Covian, PhD, Director of Technology, will give a lecture on the use of the microbiota as a potential therapeutic product in oncology as a novel treatment. David will present the latest results on our investigational new drug MVT-201 as an adjuvant to anti-PD1 immunotherapy in melanoma.

Moreover, Noelia Martinez Alvarez, Directora de I+D, will participate in a round table showcasing our commitment to innovation and scientific excellence..

🧬 This is a great opportunity to connect science, innovation and the latests trends in oncological treatments.

📷 Some pictures of the event!!